This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: The European Atomic Energy Community (Euratom), Represented by the European Commission, The European Community, Represented by the European Commission, Universitat Heidelberg. Active years: 2010-2021.
Company Filing History:
1 out of 14 
1 out of 4 
1 out of 33 
Years Active: 2010-2021
Title: Alfred Morgenstern: Innovator in Radionuclide Applications
Introduction
Alfred Morgenstern is a notable inventor based in Karlsruhe, Germany. He has made significant contributions to the field of medical radionuclides, holding 2 patents that focus on innovative treatment methods for cancers and the use of radionuclides in medicine.
Latest Patents
Morgenstern's latest patents include a method for treating PSMA expressing cancers. This invention involves administering an effective amount of one or more Ac-225-radiopharmaceuticals to patients, with dosages ranging from 25 kBq to 400 kBq/kg of body weight or a unitary dosage of 3 MBq to 30 MBq. His second patent addresses methods of using Th-226 and its mother radionuclides, such as U-230, for therapeutic, diagnostic, prophylactic, and pain palliation purposes in both human and non-human mammals.
Career Highlights
Throughout his career, Morgenstern has worked with prominent organizations, including the European Community, represented by the European Commission, and the European Atomic Energy Community (Euratom), also represented by the European Commission. His work has significantly advanced the application of radionuclides in medical treatments.
Collaborations
Morgenstern has collaborated with notable professionals in his field, including Christos Apostolidis and Roger Molinet. Their joint efforts have contributed to the development of innovative solutions in radionuclide applications.
Conclusion
Alfred Morgenstern's contributions to the field of radionuclides demonstrate his commitment to advancing medical treatments. His innovative patents and collaborations highlight his role as a key figure in this important area of research.